Isil Keskin, Isabelle Sigfridsson, Ela Skagerberg Ekhtiari, Matthew Marklund, Samuel Mattson, Thomas Brännström, Stefan L Marklund, Ulrika Nordström, Peter M Andersen
{"title":"Strain-specific morphology and CNS propagation of template-directed SOD1 aggregation following peripheral nerve inoculation.","authors":"Isil Keskin, Isabelle Sigfridsson, Ela Skagerberg Ekhtiari, Matthew Marklund, Samuel Mattson, Thomas Brännström, Stefan L Marklund, Ulrika Nordström, Peter M Andersen","doi":"10.1186/s40478-026-02455-z","DOIUrl":"10.1186/s40478-026-02455-z","url":null,"abstract":"<p><p>Accumulation of misfolded SOD1 protein into intracellular aggregates, in the spinal cord (SpC) and brainstem, is a hallmark of amyotrophic lateral sclerosis caused by mutations in the SOD1 gene (SOD1-ALS). Two distinct aggregate conformations, denoted strain A and strain B, were identified in the CNS of SOD1<sup>G85R</sup> and SOD1<sup>D90A</sup> transgenic (Tg) ALS mouse models, respectively. Both strains transmit templated SOD1 aggregation and ALS-like disease in Tg mouse models when inoculated into the SpC, whereas muscle or intraperitoneal inoculations, of up to 300 times more inoculate, did not. Here, we used strain A and strain B aggregate seeds, prepared from SpCs of the Tg mice, to investigate strain-specific differences in transmission of templated aggregation and ALS phenotype via a peripheral nerve. We show that both strains can transmit templated aggregation to the CNS via the sciatic nerve in SOD1<sup>G85R</sup> Tg mice. Strain A resulted in shorter time to disease onset and earlier end-stage disease compared to strain B, and these strain-specific differences were accentuated in the sciatic nerve inoculation model compared to direct SpC inoculations. To further analyse the differences between strain A and strain B, we developed an immunohistochemical method that distinguishes the two SOD1 aggregate strains in tissue sections. This method revealed that strain B adopts an elongated, skein-like morphology, whereas strain A aggregates appear as accumulations of rounded, bead-like structures. These findings suggest that SOD1 aggregates forming in a peripheral nerve might transmit disease to the CNS and that different SOD1 aggregate strains can influence disease onset and progression. Our results warrant further exploratory studies of SOD1 aggregate conformations and their potential role in the manifestation of SOD1 mutant-specific disease phenotypes.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149293802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Isabelle Sigfridsson, Matthew Marklund, Peter Munch Andersen, Per Zetterström, Stefan L Marklund, Thomas Brännström
{"title":"Intracisternal injection of two human SOD1 aggregate strains induces templated aggregation and ALS in transgenic mouse model.","authors":"Isabelle Sigfridsson, Matthew Marklund, Peter Munch Andersen, Per Zetterström, Stefan L Marklund, Thomas Brännström","doi":"10.1186/s40478-026-02473-x","DOIUrl":"10.1186/s40478-026-02473-x","url":null,"abstract":"<p><p>Cytosolic aggregates containing misfolded superoxide dismutase-1 (SOD1) protein is an established hallmark of ALS caused by mutations in the SOD1 gene. We have previously identified two structurally distinct strains of human (h) SOD1 aggregates (denoted A and B) in mice transgenic (Tg) for hSOD1. Strain A and B have both been shown to transmit templated aggregation and induce early-onset of fatal ALS-like disease when injected directly into the spinal cord or peripheral nerve of hSOD1 Tg mice. In contrast, peripheral administration of hSOD1 aggregates into the intraperitoneal cavity or skeletal muscle did not induce disease. Collectively, these studies provide insight on the spreading mechanism of SOD1. However, the complete map of propagation routes and underlying mechanisms utilized by SOD1 aggregates in ALS is not fully charted. Here, we investigated whether hSOD1 aggregates may spread to the central nervous system (CNS) via the cerebrospinal fluid (CSF). Mutant hSOD1 aggregate seeds or control samples prepared from spinal cords of hSOD1 Tg mice or non-Tg mice, respectively, were inoculated into the cisterna magna of adult 100-day-old Tg mice expressing the G85R mutated hSOD1 protein. Disease phenotyping as well as biochemical and immunohistochemical analyses were performed and compared across the experimental groups. The mice inoculated with hSOD1 seeds developed early signs of ALS by 90 days after inoculation and reached terminal stage approximately 180 days earlier than mice receiving control seeds. Additionally, both strain A and B were observed to initiate templated aggregation along the neuroaxis. The results show that hSOD1 aggregates are capable of transmitting from the CSF to the CNS where they induce ALS-like pathology and concomitant phenotype. Unraveling the propagation pathways utilized by SOD1 opens new avenues to assess treatment strategies against ALS.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13715270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149284746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sandra Ferreyra Vega, Ryan Shun-Yuen Kwan, Ida Rahmqvist, Elizabeth Schepke, Magnus Sabel, Thomas Olsson Bontell, Teresia Kling, Helena Carén
{"title":"Diagnostic evaluation of long-read nanopore sequencing for pediatric CNS tumors.","authors":"Sandra Ferreyra Vega, Ryan Shun-Yuen Kwan, Ida Rahmqvist, Elizabeth Schepke, Magnus Sabel, Thomas Olsson Bontell, Teresia Kling, Helena Carén","doi":"10.1186/s40478-026-02466-w","DOIUrl":"10.1186/s40478-026-02466-w","url":null,"abstract":"<p><p>Long-read nanopore sequencing enables methylation-based CNS tumor classification while providing additional genomic information within a single assay. However, its performance across molecular features relevant to pediatric CNS tumor diagnostics and across available methylation classifiers remains incompletely characterized. We evaluated nanopore sequencing for integrated molecular characterization of pediatric CNS tumors and compared with data from DNA methylation arrays and Illumina short-read sequencing used in the clinical diagnostic work-up. Twenty tumor samples representing three major pediatric CNS tumor groups (gliomas, ependymomas and medulloblastomas) were subjected to long-read nanopore sequencing, which generated robust long-read data across all tumor groups, with a mean genome coverage of approximately 40x. Nanopore-derived copy-number profiles showed good concordance with methylation array-derived profiles (median Pearson r = 0.816). Nanopore evidence was identified for 74/78 (95%) clinically relevant small variants detected by Illumina sequencing, although 53/78 (68%) were recovered as exact high-confidence nanopore calls. Structural variant profiles showed limited breakpoint overlap and differed in the number, type, and size distribution of detected events between Illumina and Nanopore sequencing. Nanopore-derived methylation classifications were largely concordant with integrated WHO CNS5 diagnoses. Ependymomas, medulloblastomas, and pilocytic astrocytomas, were concordantly classified across all evaluated classifiers, although not all classifications reached the respective classifier-specific confidence thresholds. In contrast, diffuse gliomas showed greater variability in classification across classifiers. Downsampling indicated that concordance with integrated WHO CNS5 diagnoses remained high at substantially reduced sequencing depths, whereas the proportion of classifications reaching classifier-specific confidence thresholds was more classifier dependent. Long-read nanopore sequencing enables integrated molecular characterization of pediatric CNS tumors within a single assay, although concordance with established methods varied by genomic feature and tumor type. The preservation of methylation classification performance at reduced sequencing depth supports the feasibility of shorter sequencing workflows. Prospective studies are required to establish performance and turnaround time in routine clinical diagnostics.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13711757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149284722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Constantia Zeiser, Marta Emperador, Sonja Herter, Lisa Sigaud, Alexandra Stroh-Dege, Anna Loboda, Anna Kolodziejczak, Simon Zeuner, Lea Joy Digel, Karen Frese, Bruno Chilian, Micaela Freitas, Jens M Kelm, Ingrid Ǿra, Daniel Vogl, Martin Ulrich Schuhmann, Heike Peterziel, Romain Sigaud, Florian Selt, Till Milde, Olaf Witt, Ina Oehme
{"title":"Cytotoxic activity of selinexor in BRAF<sup>V600E</sup>-driven pediatric low-grade glioma 3D cultures.","authors":"Constantia Zeiser, Marta Emperador, Sonja Herter, Lisa Sigaud, Alexandra Stroh-Dege, Anna Loboda, Anna Kolodziejczak, Simon Zeuner, Lea Joy Digel, Karen Frese, Bruno Chilian, Micaela Freitas, Jens M Kelm, Ingrid Ǿra, Daniel Vogl, Martin Ulrich Schuhmann, Heike Peterziel, Romain Sigaud, Florian Selt, Till Milde, Olaf Witt, Ina Oehme","doi":"10.1186/s40478-026-02461-1","DOIUrl":"10.1186/s40478-026-02461-1","url":null,"abstract":"<p><p>Pediatric low-grade gliomas (pLGGs) are the most common primary brain tumors in children and frequently harbor activating RAS/MAPK pathway alterations, including BRAF<sup>V600E</sup>. Although MEK inhibitors (MEKi) show clinical activity, responses are often incomplete and tumors commonly regrow after treatment discontinuation, highlighting the need for therapies that induce sustained regression. To systematically identify cytotoxic treatments, we initially screened 87 clinically relevant drugs in BRAF<sup>V600E</sup>-mutant BT40 3D multicellular aggregates and subsequently evaluated the prioritized XPO1-targeting strategy in BRAF<sup>V600E</sup>-mutant DKFZ-BT314 spheroids in proliferative (ON) and senescent (OFF) states and in fresh pLGG tissue cultures. High-content imaging with machine-learning-based analysis identified XPO1 inhibition as a vulnerability across models. The FDA-approved selective XPO1 inhibitor selinexor was active alone and in combination with MEKi. MEK-XPO1 co-inhibition reduced viable 3D culture area by more than 30% and suppressed regrowth for at least 10 d, even after medium change. DRAQ7 positivity and caspase-3/7 activation demonstrated cell death in the 3D cultures, while complementary 2D analyses showed PARP cleavage, nuclear fragmentation, and caspase activation. Transcriptomic analyses of pleomorphic xanthoastrocytoma patient samples and BRAF<sup>V600E</sup>-induced senescence models revealed upregulation of MAPK, TGFβ, TP53, and FOXO pathway genes and anti-apoptotic BCL2 family members, including MCL-1. XPO1 inhibition reduced MCL-1 protein levels, consistent with disruption of anti-apoptotic signaling. Ex vivo drug sensitivity profiling of fresh tumor tissue from 20 patients from the LOGGIC Core BioClinical Data Bank demonstrated sensitivity to XPO1 inhibition at clinically achievable concentrations. In an exploratory BT40 zebrafish embryo xenograft experiment, 48 h of combination treatment numerically attenuated tumor growth compared with solvent treatment, although the difference was not statistically significant. Overall, our findings support XPO1 inhibition, alone or combined with MEK inhibition, as a candidate therapeutic strategy for BRAF<sup>V600E</sup>-driven pLGG that warrants further preclinical evaluation.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13689195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149242390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kuo Liao, Jianing Lin, Yangfan Zhou, Sebastian A Lewandowski
{"title":"Vascular profiling of the spinal cord and cortex reveals region-specific endothelial dysfunction and fibroblast remodeling in human ALS.","authors":"Kuo Liao, Jianing Lin, Yangfan Zhou, Sebastian A Lewandowski","doi":"10.1186/s40478-026-02449-x","DOIUrl":"10.1186/s40478-026-02449-x","url":null,"abstract":"<p><p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive degeneration of upper and lower motor neurons. Increasing evidence suggests that neurovascular dysfunction contributes to ALS pathogenesis, but a comprehensive understanding of vascular cell alterations in the human central nervous system remains lacking. Here, to systematically characterize neurovascular changes in ALS, we curated single-nucleus transcriptomic datasets from human spinal cord and cortical tissues with a specific focus on vascular cell populations. Comparative analyses revealed substantial vascular perturbations in the spinal cord compared to the cortex. Among vascular-associated cell populations, endothelial cells and fibroblasts exhibited the most pronounced transcriptional alterations. Endothelial cells from ALS spinal cords displayed reduced blood-brain barrier integrity signatures and increased expression of inflammatory and stress-response programs, with the greatest changes manifested in capillary endothelial cells. In parallel, we generated a refined cellular atlas of spinal cord fibroblasts and identified three major fibroblast populations, including a distinct LAMA1<sup>low</sup> perivascular fibroblast subtype. Fibroblast signatures were found to be consistently elevated in ALS across single-nucleus transcriptomic, bulk transcriptomic, and experimental validation datasets. Together, our findings establish a region-resolved view of neurovascular alternations in human ALS, which is characterized by endothelial barrier dysfunction and disease-associated remodeling of specialized perivascular fibroblasts. These findings broaden the cellular framework of ALS pathogenesis beyond neuronal and glial alterations and highlight the neurovascular niche as an integral component of human ALS disease biology.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13660197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Constanza Bravo-Rossainz Baez, Xian Xin, Hang Lyu, Daniil Kirianov, Ying Sun, Erik Späte, Mariapia Grassia, Birgit Engeland, Malte Stockebrand, Konstantin Khodosevich, Ulrike B S Hedrich, Dirk Isbrandt, Friederike Pfeiffer
{"title":"Altered oligodendroglial cell development and increased myelination in SCN2A gain-of-function-linked epilepsy.","authors":"Constanza Bravo-Rossainz Baez, Xian Xin, Hang Lyu, Daniil Kirianov, Ying Sun, Erik Späte, Mariapia Grassia, Birgit Engeland, Malte Stockebrand, Konstantin Khodosevich, Ulrike B S Hedrich, Dirk Isbrandt, Friederike Pfeiffer","doi":"10.1186/s40478-026-02437-1","DOIUrl":"10.1186/s40478-026-02437-1","url":null,"abstract":"<p><p>Gain-of-function variants in SCN2A, encoding the voltage-gated sodium channel Na<sub>V</sub>1.2, cause developmental and epileptic encephalopathies characterized by seizures, developmental delay, and white matter abnormalities. While Na<sub>V</sub>1.2 is known to regulate neuronal excitability, its role in oligodendroglial cells is unclear. Here, we show that Na<sub>V</sub>1.2 is expressed in early oligodendrocyte lineage stages. In mice carrying the gain-of-function Scn2a<sup>p.A263V</sup> variant, oligodendrocyte precursor cells displayed similar Na<sub>V</sub>1.2 expression, but altered electrophysiological properties and calcium signaling. Single-cell transcriptomics revealed stage-specific changes in oligodendroglial maturation during early postnatal development, associated with lower variability and slightly faster conduction velocities. In adult mutant mice, gray matter myelination was increased without changes in oligodendrocyte numbers or myelin structure. Since Na<sub>V</sub>1.2 was absent from mature oligodendrocytes, the enhanced myelination likely reflects an activity-dependent adaptation to altered neuronal network activity rather than a primary myelinopathy. These findings identify a glial contribution to SCN2A-related disease mechanisms and underscore the need to consider neuron-glia interactions when developing targeted therapies for epilepsy.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13651182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jie Pan, Jaume Fores-Martos, Claire Delpirou Nouh, Tanner D Jensen, Kristen Vallejo, Romain Cayrol, Saman Ahmadian, Euan A Ashley, Michael D Greicius, Inma Cobos
{"title":"Correction to: Deciphering glial contributions to CSF1R-related disorder via single-nuclear transcriptomic profiling: a case study.","authors":"Jie Pan, Jaume Fores-Martos, Claire Delpirou Nouh, Tanner D Jensen, Kristen Vallejo, Romain Cayrol, Saman Ahmadian, Euan A Ashley, Michael D Greicius, Inma Cobos","doi":"10.1186/s40478-026-02443-3","DOIUrl":"10.1186/s40478-026-02443-3","url":null,"abstract":"","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13640113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149102520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jonas Rotter, Toni Kirmann, Jana Brendler, Larissa Anthofer, Nina Maria Wilpert, Stefan Hallermann, Heike Biebermann, Ingo Bechmann
{"title":"Multiscale characterization and distribution of the thyroid hormone transporter MCT8 in the adult and aged human brain.","authors":"Jonas Rotter, Toni Kirmann, Jana Brendler, Larissa Anthofer, Nina Maria Wilpert, Stefan Hallermann, Heike Biebermann, Ingo Bechmann","doi":"10.1186/s40478-026-02435-3","DOIUrl":"10.1186/s40478-026-02435-3","url":null,"abstract":"<p><p>The local availability of thyroid hormones (TH) depends on TH transporters such as monocarboxylate transporter 8 (MCT8, encoded by SLC16A2). Mutations of SLC16A2 cause Allan-Herndon-Dudley syndrome (AHDS), a disorder characterized by severe neurodevelopmental and motor deficits. While MCT8's importance in foetal brain development is well-established, its precise topographical, cellular, and subcellular distribution in the adult human brain has remained largely uncharacterized, limiting our understanding of which structures depend on MCT8-mediated TH transport throughout life and whether neurodegenerative processes such as Alzheimer's disease (AD) affect local transporter availability. In this study, we systematically mapped MCT8 expression across eight functionally distinct brain regions from 14 aged human body donors. Our multiscale approach combined immunostaining, automated whole-slide image analysis of over 13 million cells, multiplex RNAscope in situ hybridization, stimulated emission depletion (STED) microscopy, and single-nucleus RNA sequencing data analysis. We additionally applied standardized Braak staging to investigate whether AD progression correlates with alterations in MCT8 expression. We demonstrate robust MCT8 expression across brain barriers, glial cells, and in distinct neuronal populations. RNAscope confirmed a strong concordance between SLC16A2 mRNA presence and MCT8 immunoreactivity. STED and confocal microscopy localized MCT8 to plasma membranes, perinuclear regions, and axonal/dendritic compartments, indicating roles in both trans- and intracellular TH transport. MCT8 expression was preserved across Braak stages, with no significant difference between donors with varying degrees of neurofibrillary pathology. Our findings establish a comprehensive cellular and regional framework for MCT8-mediated transport in the human brain, mapping its specific anatomical distribution across regions crucial for motor control and cognitive processing. Stable MCT8 expression across Braak stages suggests that cerebral TH dysregulation in AD likely reflects altered hormone metabolism rather than transporter loss.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13632270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149102590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zahra Nassiri Toosi, Santiago A Forero, Ali Pirani, Sumod Sebastian, Tao Wang, Xiaofeng Zheng, Kerry C Roby, John E Morales, Joseph H McCarty
{"title":"Loss of GlialCAM cytoplasmic signaling drives cerebellar white matter vacuolation through glial reprogramming and disrupted cell-cell communication.","authors":"Zahra Nassiri Toosi, Santiago A Forero, Ali Pirani, Sumod Sebastian, Tao Wang, Xiaofeng Zheng, Kerry C Roby, John E Morales, Joseph H McCarty","doi":"10.1186/s40478-026-02428-2","DOIUrl":"10.1186/s40478-026-02428-2","url":null,"abstract":"<p><p>Glial cell adhesion molecule (GlialCAM) is a transmembrane protein enriched in astrocytes and oligodendrocytes and is required for white matter homeostasis. While prior studies have focused on extracellular cell-cell adhesion functions for GlialCAM, the contribution of its cytoplasmic signaling domain remains unclear. Here, we generated a mouse model, termed GCAMΔCT, in which the cytoplasmic tail of GlialCAM is selectively deleted in the brain while preserving its extracellular and transmembrane domains. Mutant mice develop progressive vacuolation of cerebellar white matter, accompanied by deficits in motor coordination and recognition memory. Histological and ultrastructural analyses revealed widespread disruption of myelinated tracts. Single-cell RNA sequencing of cortical and cerebellar regions identified broad transcriptional reprogramming in glial cells, characterized by upregulation of inflammatory pathways and extracellular matrix (ECM) remodeling programs. Spatial transcriptomic analysis localized these transcriptional changes to vacuolated white matter regions, where astrocytes and oligodendrocytes exhibited increased expression of ECM components and reactive glial markers. Integration of single-cell and spatial datasets further revealed a marked reduction in glial cell-cell communication networks, including loss of trophic and neurotransmitter-associated signaling pathways, together with increased signaling associated with ECM remodeling and stress responses. Collectively, these findings indicate that the GlialCAM cytoplasmic domain is necessary for normal white matter structure and function and suggest that this occurs at least in part through alterations in glial transcriptional programs and cell-cell signaling networks.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13741419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149369727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hanna Gött, Jonas Tellermann, Hannes Becker, Christina Fodi, Peter Paßlack, Elgin Hoffmann, Maria Elisa Di Francesco, Daniel J Merk, Jürgen Honegger, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Jens Schittenhelm
{"title":"The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas.","authors":"Hanna Gött, Jonas Tellermann, Hannes Becker, Christina Fodi, Peter Paßlack, Elgin Hoffmann, Maria Elisa Di Francesco, Daniel J Merk, Jürgen Honegger, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Jens Schittenhelm","doi":"10.1186/s40478-026-02419-3","DOIUrl":"10.1186/s40478-026-02419-3","url":null,"abstract":"<p><strong>Background: </strong>Despite best clinical management, patients with meningiomas frequently experience tumor recurrence. During recent decades, efforts have been made to improve the prognostic stratification of meningiomas by incorporating molecular data. A subgroup of tumors harboring a homozygous CDKN2A deletion was identified, and a higher risk of tumor progression was observed, suggesting the potential use of cyclin-dependent kinases as biomarkers.</p><p><strong>Material and methods: </strong>In this retrospective single-center study, the immunohistochemical staining for the cyclin-dependent kinases p16, phosphoRB1 (pRB1), CDK4 and CDK6 was analyzed in 1751 paraffin-embedded meningioma samples. For the assessment of p16, CDK4 and CDK6, a semi-quantitative score was applied, whereas an automated quantification tool was used for pRB1. The distribution and association with histopathological results, clinical data and progression-free survival (PFS)-defined by radiographic tumor recurrence-were assessed.</p><p><strong>Results: </strong>Of all meningioma samples, 14.9% (n = 261) expressed p16. Elevated pRB1 levels were found in 34.5% (n = 589) of tumor samples. CDK4 and CDK6 positive staining was observed in 41.9% and 42.2% of cases, respectively. Dichotomous stratification of meningiomas based on p16 and pRB1 expression levels suggested a significant influence on PFS in univariate analyses. Multivariate analysis determined elevated pRB1 expression, WHO grading, extent of resection, adjuvant radiotherapy, male gender, NF2-status and an elevated MIB1 index as independent prognostic factors.</p><p><strong>Conclusions: </strong>High expression of pRB1 is an independent prognostic factor for shorter PFS. The prognostic impact of p16 is mostly attributed to the confounding increase of pRB1 expression.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"14 1","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148904963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}